Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Chronic ischemic heart disease

Citations 281-290 of 1251 total displayed.

Past content (since Jan 1999):

Editorials
Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics?
Caroline Kistorp
Circulation 2006;114:184-186, doi:10.1161/CIRCULATIONAHA.106.639732 [Full text]  

Epidemiology
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Stefan Blankenberg, Matthew J. McQueen, Marek Smieja, Janice Pogue, Cynthia Balion, Eva Lonn, Hans J. Rupprecht, Christoph Bickel, Laurence Tiret, Francois Cambien, Hertzel Gerstein, Thomas Münzel, Salim Yusuf for the HOPE Study Investigators
Circulation 2006;114:201-208; published online before print as doi:10.1161/CIRCULATIONAHA.105.590927 [Abstract] [Full text]  

Contemporary Reviews in Cardiovascular Medicine
Complete Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention
Andrew T.L. Ong and Patrick W. Serruys
Circulation 2006;114:249-255, doi:10.1161/CIRCULATIONAHA.106.614420 [Full text]  

Preventive Cardiology
Healthy Lifestyle Factors in the Primary Prevention of Coronary Heart Disease Among Men: Benefits Among Users and Nonusers of Lipid-Lowering and Antihypertensive Medications
Stephanie E. Chiuve, Marjorie L. McCullough, Frank M. Sacks, and Eric B. Rimm
Circulation 2006;114:160-167; published online before print as doi:10.1161/CIRCULATIONAHA.106.621417 [Abstract] [Full text]  

Articles
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Stefan Blankenberg, Matthew J. McQueen, Marek Smieja, Janice Pogue, Cynthia Balion, Eva Lonn, Hans J. Rupprecht, Christoph Bickel, Laurence Tiret, Francois Cambien, Hertzel Gerstein, Thomas Münzel, Salim Yusuf for the HOPE Study Investigators
Circulation published July 10, 2006, doi:10.1161/CIRCULATIONAHA.105.590927 [Abstract]  

Editorials
Chronic Kidney Disease: Tipping the Scale to the Benefit of Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease
Peter A. McCullough
Circulation 2006;114:6-7, doi:10.1161/CIRCULATIONAHA.106.636662 [Full text]  

Editorials
"Shades of Gray" in Cardiac Magnetic Resonance Images of Infarcted Myocardium: Can They Tell Us What We’d Like Them to?
Francis J. Klocke, Edwin Wu, and Daniel C. Lee
Circulation 2006;114:8-10, doi:10.1161/CIRCULATIONAHA.106.636456 [Full text]  

Coronary Heart Disease
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial
Scott D. Solomon, Madeline M. Rice, Kathleen A. Jablonski, Powell Jose, Michael Domanski, Marc Sabatine, Bernard J. Gersh, Jean Rouleau, Marc A. Pfeffer, Eugene Braunwald for the Prevention of Events with ACE inhibition (PEACE) Investigators
Circulation 2006;114:26-31; published online before print as doi:10.1161/CIRCULATIONAHA.105.592733 [Abstract] [Full text]  

Imaging
Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality
Andrew T. Yan, Adolphe J. Shayne, Kenneth A. Brown, Sandeep N. Gupta, Carmen W. Chan, Tuan M. Luu, Marcelo F. Di Carli, H. Glenn Reynolds, William G. Stevenson, and Raymond Y. Kwong
Circulation 2006;114:32-39; published online before print as doi:10.1161/CIRCULATIONAHA.106.613414 [Abstract] [Full text]  

Cardiac Transplantation and Surgery for Congestive Heart Failure
Low-Dose Dobutamine Tissue-Tagged Magnetic Resonance Imaging With 3-Dimensional Strain Analysis Allows Assessment of Myocardial Viability in Patients With Ischemic Cardiomyopathy
Douglas Bree, Jason R. Wollmuth, Brian P. Cupps, Marc D. Krock, Analyn Howells, Joseph Rogers, Nader Moazami, and Michael K. Pasque
Circulation 2006;114:I-33-36I-, doi:10.1161/CIRCULATIONAHA.105.000885 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126

* Subspecialty Collections Home

* Show  Chronic ischemic heart disease
 collections from other journals.

* Related collections:
 Etiology
 Acute coronary syndromes
 Acute myocardial infarction
 Arrhythmias, clinical electrophysiology, drugs
 Cardiac development
 Chronic ischemic heart disease
 Clinical genetics
 Epidemiology
 Heart failure
 Hypertension
 Hypertrophy
 Infectious endocarditis
 Lipids
 Myocardial cardiomyopathy disease
 Obesity
 Pericardial disease
 Peripheral vascular disease
 Pulmonary circulation and disease
 Remodeling
 Restenosis
 Valvular heart disease
 Other etiology